longevity

Reframe Daily: Twice-Yearly HIV Protection Shot, FDA-Approved Bladder Implant & 4 More Advances

Skip 93 headlines and save 14 hours—twice-a-year HIV protection, a bladder-calming implant, magnet-powered bariatric surgery, and other fast-approaching fixes are all inside this quick roundup.

building reframescience.org neuroscience phd, chaplain, healthtech strategy consultant. co-host of the /okbanger show and vibe imagineer for /christin.

Neuspera’s tiny nerve-stimulation implant wins FDA OK to calm “gotta-go” bladder troubles

Why it’s good news: The match-stick-size device sends gentle signals to bladder nerves so people can worry less about sudden leaks and bathroom runs.

Market readiness: 😊😊😊😊 (cleared by FDA; surgeons can start offering it)

US FDA approves Gilead’s twice-yearly shot that helps stop HIV before it starts

Why it’s good news: A single injection in each arm, just twice a year, can keep people from getting HIV. That means fewer pills to remember and a big step toward ending new HIV infections.

Market readiness: 😊😊😊😊 (FDA-approved and rolling out soon)

Reframe Daily is where Christin Chong (neuroscience PhD, chaplain, healthcare strategy consultant) curates optimistic and credible AI + healthcare news so you don’t have to.

Barista in the morning, AI engineer by day, and parent (with @shiwen) by night ||
Host at /clickcast /cpg

we are sick in the head 🤣 🤣 🤣 

what's the copy you are workshopping?? i wanna know~

Not quite right but we’re working on it

@fffflood knows I’ve been workshopping the copy for something for god knows.. almost 6 months now and off and I still can’t get it right

@jachian 😵‍💫 "health news for caring scientific minds" is awkward but shifting towards the type of person rather than the type of content...

hopefully 🙏 it seems they still have pricing issues but at least they are working with generic drug makers to reduce the cost a bit...

I’m so happy tho
This is groundbreaking
Definitely sharing this with my class mates!

hopefully 🙏 it seems they still have pricing issues but at least they are working with generic drug makers to reduce the cost a bit...

https://apnews.com/article/hiv-prevention-shot-lenacapavir-gilead-80fb37e2c5ac9b452488d7b86a10d568

Subscribedd!
Gilead’s shot?
First time hearing about them Long-acting prevention like this changes the game less stigma, less burden, more access. One step closer to making “zero new infections” more than just a slogan.